灵活的DCT技术，您可以信任的体验
IQVIA分散式临床试验平台是一种智能，高度可配置和可扩展的SAAS解决方案，可提高患者体验，降低现场负担，降低研究时间表以获得更好的试验结果。了解为什么IQVIA的混合DCT解决方案超过任何其他方法。1
1行业标准研究，2021
Patient-centric by design
Built by one of biopharma’s most trusted decentralized trials solution providers, IQVIA Decentralized Clinical Trials Platform was designed to address some of the most common challenges in hybrid trials, including:
- Integration with patient recruitment
- Improved patient engagement
- 增加研究团队合作
- 流线型的端点数据流
With this platform, IQVIA aims to empower any sponsor to deploy adaptable, patient-centric DCT technology for any study and any indication – anywhere on the globe.
行业领先的混合解决方案
〜67％的行业专家在混合试用解决方案提供商中排名IQVIA - 比任何其他技术或服务提供商更多90个国家的90项研究
IQVIA分散试验solutions>注册了210k科目
在IQVIA跨越30岁以上的分散试验
Built on a foundation of deep clinical operations knowhow
DCT要求不仅仅是技术。IQVIA具有临床操作专业知识，治疗专业知识和全球范围，以确保赞助商从我们的技术解决方案中获得最大值。
我们的DCT产品包括专门的学习团队，访问参与者的家园和将DCT生态系统 - 从econent和Irt连接到Ecoa和连接设备的技术。
IQVIA分散试验and Technology Suite delivers the adaptability and scale to meet any sponsor’s requirements – small or large, local or global.
Power your decentralized trial with an agile randomization and trial supply management solution that supports supply flexibility and optimization as well as adaptable direct to patient options.
Deliver eConsent to sites and study participants around the globe with confidence
Discover intelligent insights from streamlined data and sophisticated analytics to transform trial workflows.